Preoperative staging of non-small-cell lung cancer: Comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/ computed tomography

European Radiology

Volumn 22, Issue 12, 2012, Pages 2859-2867

  Sommer, Gregor ^a   Wiese, Mark ^a   Winter, Leopold ^a   Lenz, Claudia ^a   Klarhöfer, Markus ^a,b   Forrer, Flavio ^a   Lardinois, Didier ^a   Bremerich, Jens ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Siemens Schweiz AG   (Switzerland)

Author keywords

Diffusion magnetic resonance imaging; Neoplasm staging; Non small cell lung carcinoma; Positron emission tomography; Whole body imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINATED CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; ARTIFACT; CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER SCINTISCANNING; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG SCINTISCANNING; LYMPH NODE METASTASIS; MALE; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; WHOLE BODY MRI;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

EID: 84870339357     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2542-y     Document Type: Article

References (31)

1. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236
2. Toloza EM, Harpole L, McCrory DC (2003) Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123: 137S-146S
3. Lardinois D,WederW, Hany TF et al (2003) Staging of non-smallcell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348: 2500-2507
4. Aquino SL, Kuester LB, Muse VV, Halpern EF, Fischman AJ (2006) Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT. Eur J Nucl Med Mol Imaging 33: 692-696
5. Roberts PF, Follette DM, von Haag D et al (2000) Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 70: 1154-1160
6. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M (2004) Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22: 275-282
7. Matsumoto Y, Kuroda M, Matsuya R et al (2009) In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology. Oncol Rep 22: 641-648
8. Kwee TC, Takahara T, Ochiai R, Nievelstein RAJ, Luijten PR (2008) Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18: 1937-1952
9. Mori T, Nomori H, Ikeda K et al (2008) Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol 3: 358-364
10. Ohba Y, Nomori H, Mori T et al (2009) Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer? J Thorac Cardiovasc Surg 138: 439-445
11. Usuda K, Zhao XT, Sagawa M et al (2011) Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers. Ann Thorac Surg 91: 1689-1695
12. Chen W, Jian W, H-tao L et al (2010) Whole-body diffusionweighted imaging vs. FDG-PET for the detection of non-smallcell lung cancer. How do they measure up? Magn Reson Imaging 28: 613-620
13. Nomori H, Mori T, Ikeda K et al (2008) Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg 135: 816-822
14. Ohno Y, Koyama H, Yoshikawa T et al (2011) N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. Radiology 261: 605-615
15. Ohno Y, Koyama H, Onishi Y et al (2008) Non-small cell lung cancer: whole-body MR examination for M-stage assessment - utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 248: 643-654
16. Satoh S, Kitazume Y, Ohdama S, Kimula Y, Taura S, Endo Y (2008) Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? AJR Am J Roentgenol 191: 464-470
17. Uto T, Takehara Y, Nakamura Y et al (2009) Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 252: 247-254
18. Takenaka D, Ohno Y, Matsumoto K et al (2009) Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging 30: 298-308
19. Nakayama J, Miyasaka K, Omatsu T et al (2010) Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 34: 1-8
20. Liu H, Liu Y, Yu T, Ye N (2012) Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions. Eur Radiol 20: 807-815
21. Pauls S, Schmidt SA, Juchems MS et al (2010) Diffusion-weighted MR imaging in comparison to integrated [(18)F]-FDG PET/CT for N-staging in patients with lung cancer. Eur J Radiol 81: 178-182
22. Hasegawa I, Boiselle PM, Kuwabara K, Sawafuji M, Sugiura H (2008) Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging. J Thorac Imaging 23: 157-161
23. Matoba M, Tonami H, Kondou T et al (2007) Lung carcinoma: diffusion-weighted MR imaging - preliminary evaluation with apparent diffusion coefficient. Radiology 243: 570-577
24. Koşucu P, Tekinbaş C, Erol M et al (2009) Mediastinal lymph nodes: assessment with diffusion-weighted MR imaging. J Magn Reson Imaging 30: 292-297
25. Travis WD, Colby TV, Corrin B et al (1999) Histological typing of lung and pleural tumours, 3rd edn. Springer, Berlin Heidelberg
26. UyBico SJ, Wu CC, Suh RD, Le NH, Brown K, Krishnam MS (2010) Lung cancer staging essentials: the new TNM staging system and potential imaging pitfalls. Radiographics 30: 1163-1181
27. Rusch VW, Asamura H, Watanabe H et al (2009) The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 4: 568-577
28. Subedi N, Scarsbrook A, Darby M, Korde K, Mc Shane P, Muers MF (2009) The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer. Lung Cancer 64: 301-307
29. Muehling B,Wehrmann C, Oberhuber A, Schelzig H, Barth T, Orend KH (2012) Comparison of Clinical and Surgical-Pathological Staging in IIIA Non-Small Cell Lung Cancer Patients. Ann Surg Oncol 19: 89-93
30. Billé A, Pelosi E, Skanjeti A et al (2009) Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg 36: 440-445
31. Li X, Zhang H, Xing L et al (2011) Mediastinal lymph nodes staging by (18)F-FDG PET/CT for early stage non-small cell lung cancer: A multicenter study. Radiother Oncol 102: 246-250.